GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (STU:LSI) » Definitions » 3-Year FCF Growth Rate

CK Life Sciences International Holdings (STU:LSI) 3-Year FCF Growth Rate : 12.90% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings 3-Year FCF Growth Rate?

CK Life Sciences International Holdings's Free Cash Flow per Share for the six months ended in Dec. 2023 was €0.01.

During the past 12 months, CK Life Sciences International Holdings's average Free Cash Flow per Share Growth Rate was 53.30% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of CK Life Sciences International Holdings was 81.70% per year. The lowest was -48.20% per year. And the median was 12.90% per year.


Competitive Comparison of CK Life Sciences International Holdings's 3-Year FCF Growth Rate

For the Biotechnology subindustry, CK Life Sciences International Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's 3-Year FCF Growth Rate falls into.



CK Life Sciences International Holdings 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


CK Life Sciences International Holdings  (STU:LSI) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


CK Life Sciences International Holdings 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (STU:LSI) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.